1. Home
  2. NAII vs HCWB Comparison

NAII vs HCWB Comparison

Compare NAII & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAII
  • HCWB
  • Stock Information
  • Founded
  • NAII 1980
  • HCWB 2018
  • Country
  • NAII United States
  • HCWB United States
  • Employees
  • NAII N/A
  • HCWB N/A
  • Industry
  • NAII Medicinal Chemicals and Botanical Products
  • HCWB Biotechnology: Pharmaceutical Preparations
  • Sector
  • NAII Health Care
  • HCWB Health Care
  • Exchange
  • NAII Nasdaq
  • HCWB Nasdaq
  • Market Cap
  • NAII 18.6M
  • HCWB 16.1M
  • IPO Year
  • NAII 1987
  • HCWB 2021
  • Fundamental
  • Price
  • NAII $3.43
  • HCWB $6.04
  • Analyst Decision
  • NAII
  • HCWB Strong Buy
  • Analyst Count
  • NAII 0
  • HCWB 1
  • Target Price
  • NAII N/A
  • HCWB $35.00
  • AVG Volume (30 Days)
  • NAII 5.0K
  • HCWB 2.0M
  • Earning Date
  • NAII 05-14-2025
  • HCWB 05-15-2025
  • Dividend Yield
  • NAII N/A
  • HCWB N/A
  • EPS Growth
  • NAII N/A
  • HCWB N/A
  • EPS
  • NAII N/A
  • HCWB N/A
  • Revenue
  • NAII $125,483,000.00
  • HCWB $1,445,145.00
  • Revenue This Year
  • NAII N/A
  • HCWB N/A
  • Revenue Next Year
  • NAII N/A
  • HCWB N/A
  • P/E Ratio
  • NAII N/A
  • HCWB N/A
  • Revenue Growth
  • NAII 4.39
  • HCWB N/A
  • 52 Week Low
  • NAII $2.57
  • HCWB $5.00
  • 52 Week High
  • NAII $6.88
  • HCWB $100.80
  • Technical
  • Relative Strength Index (RSI)
  • NAII 61.23
  • HCWB 36.83
  • Support Level
  • NAII $3.20
  • HCWB $7.55
  • Resistance Level
  • NAII $3.42
  • HCWB $6.68
  • Average True Range (ATR)
  • NAII 0.08
  • HCWB 0.64
  • MACD
  • NAII 0.01
  • HCWB -0.20
  • Stochastic Oscillator
  • NAII 83.52
  • HCWB 9.37

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Share on Social Networks: